Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Amer H. Zureikat"'
Autor:
Fabio Casciani, Maxwell T. Trudeau, Horacio J. Asbun, Chad G. Ball, Claudio Bassi, Stephen W. Behrman, Adam C. Berger, Mark P. Bloomston, Mark P. Callery, John D. Christein, Massimo Falconi, Carlos Fernandez-del Castillo, Mary E. Dillhoff, Euan J. Dickson, Elijah Dixon, William E. Fisher, Michael G. House, Steven J. Hughes, Tara S. Kent, John W. Kunstman, Giuseppe Malleo, Stefano Partelli, Christopher L. Wolfgang, Amer H. Zureikat, Charles M. Vollmer, George Van Buren, Wande B. Pratt, Ammara A. Watkins, Joal D. Beane, Ammar A. Javed, Katherine E. Poruk, Kevin C. Soares, Vicente Valero, Zhi V. Fong, John A. Stauffer, Mary E. Dilhoff, Ericka N. Haverick, Carl R. Schmidt, Robert H. Hollis, Jeffrey A. Drebin, Brett Ecker, Russell Lewis, Matthew McMillan, Benjamin Miller, Priya Puri, Thomas Seykora, Michael J. Sprys, Stacy J. Kowalsky, Laura Maggino, Roberto Salvia, Giulia Savegnago, Lorenzo Cinelli, Nigel B. Jamieson, Lavanniya K.P. Velu, Ronald R. Salem
Publikováno v:
Surgery. 170:1195-1204
Background: The association between intraoperative estimated blood loss and outcomes after pancreatoduodenectomy has, thus far, been rarely explored. Methods: In total, 7,706 pancreatoduodenectomies performed at 18 international institutions composin
Autor:
Alessandro Paniccia, Nathan Bahary, David L Bartlett, Kenneth K. Lee, Kenneth J. Smith, Amer H. Zureikat, Caroline J. Rieser, Sowmya Narayanan
Publikováno v:
J Surg Oncol
INTRODUCTION: Neoadjuvant therapy (NAT) is an emerging strategy for operable pancreatic ductal adenocarcinoma (PDAC). While neoadjuvant therapy increases multimodal therapy completion, it risks functional decline and treatment drop out. We used decis
Autor:
Brian A. Boone, Kelsey A. Musgrove, Carl Schmidt, Alan A Thomay, Pavan Rao, Britney R. Harris, Melissa E. Hogg, Herbert J. Zeh, Amer H. Zureikat, J. Wallis Marsh
Publikováno v:
J Surg Oncol
Introduction The learning curve associated with robotic pancreatoduodenectomy (RPD) is a hurdle for new programs to achieve optimal results. Since early analysis, robotic training has recently expanded, and the RPD approach has been refined. The purp
Autor:
Brian A. Boone, Joal D. Beane, Mazen S. Zenati, Herbert J. Zeh, A. James Moser, Melissa E. Hogg, David L. Bartlett, Amr I. Al Abbas, Amer H. Zureikat
Publikováno v:
Ann Surg
OBJECTIVES: This study aims to present the outcomes of our decade-long experience of robotic pancreatoduodenectomy and provide insights into successful program implementation. BACKGROUND: Despite significant improvement inmortality over the past 30 y
Autor:
Amr Al-abbas, Melissa E. Hogg, Caroline J. Rieser, Matthew D. Neal, Amer H. Zureikat, Mazen S. Zenati, Brian A. Boone, Ahmad Hamad, Herbert J. Zeh
Publikováno v:
Annals of Surgical Oncology. 26:1503-1511
Pancreatic ductal adenocarcinoma (PDA) is associated with a hypercoagulable state, resulting in a high risk of venous thromboembolism (VTE). Risk of VTE is well established for patients receiving chemotherapy for advanced disease and during the perio
Autor:
Mohamed A. Adam, Amer H. Zureikat, Stacy J. Kowalsky, Ibrahim Nassour, Alessandro Paniccia, Aatur D. Singhi, Nathan Bahary, Kenneth K.W. Lee, Samer Al Masri
Publikováno v:
Journal of surgical oncologyREFERENCES. 123(1)
BACKGROUND There are limited data on the efficacy of neoadjuvant therapy (NAT) for early-stage distal pancreas adenocarcinoma (PDAC). Previous studies focused on adenocarcinoma of the head of the pancreas or dealt with borderline and locally advanced
Autor:
Dana H. Bovbjerg, Steven S. Ahrendt, Carissa A. Low, Matthew P. Holtzman, M. Haroon A. Choudry, David L. Bartlett, Amer H. Zureikat, Herbert J. Zeh, Heather L. Jones, Lekshmi Ramalingam, James F. Pingpank
Publikováno v:
Annals of Behavioral Medicine. 52:88-92
Background Postoperative ambulation is encouraged to promote timely recovery but is rarely monitored objectively or examined as a predictor of clinical outcomes, despite growing availability of wearable devices that allow passive quantification and r
Autor:
Matthew P. Holtzman, Melissa E. Hogg, J. Wallis Marsh, David L. Bartlett, James F. Pingpank, Mashaal Dhir, Amer H. Zureikat, David A. Geller, M. Haroon A. Choudry, Herbert J. Zeh, Heather L. Jones, Mazen S. Zenati, Nathan Bahary, Allan Tsung
Publikováno v:
Annals of Surgical Oncology. 25:550-557
In the era of modern effective systemic chemotherapy, the comparative effectiveness of hepatic artery infusion (HAI) versus selective internal radiation therapy (yttrium-90 [Y90]) for pretreated patients with isolated unresectable colorectal liver me
Autor:
Yongli Shuai, David L. Bartlett, Matthew P. Holtzman, Steven S. Ahrendt, Herbert J. Zeh, James F. Pingpank, Haroon A. Choudry, Heather L. Jones, Lekshmi Ramalingam, Amer H. Zureikat, Sam Pakraftar
Publikováno v:
Annals of Surgical Oncology. 24:3811-3817
Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion (CRS-HIPEC) is a complex procedure that often requires ostomy creation to protect high-risk anastomoses. This study aimed to evaluate the authors’ institutional experience with C
Autor:
Kenneth K. Lee, James W. Marsh, Herbert J. Zeh, Melissa E. Hogg, Randall E. Brand, Georgios I. Papachristou, Kevin McGrath, David L. Bartlett, Marina N. Nikiforova, Adam Slivka, Sara E. Monaco, Allan Tsung, Kenneth E. Fasanella, James F. Pingpank, Abigail I. Wald, Anil K. Dasyam, Jennifer Chennat, Aatur D. Singhi, Amer H. Zureikat, N. Paul Ohori, Asif Khalid
Publikováno v:
Gut
ObjectiveDNA-based testing of pancreatic cyst fluid (PCF) is a useful adjunct to the evaluation of pancreatic cysts (PCs). Mutations in KRAS/GNAS are highly specific for intraductal papillary mucinous neoplasms (IPMNs) and mucinous cystic neoplasms (